← Open Payments lookup

WILLIAM KERNODLE: Open Payments

NPI 1699765024 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,657 in 153 payments from 20 companies in 2025. Trend: 2023 $2,446 · 2024 $2,378 · 2025 $2,657

Food & beverage: $2,657
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.17$356
Neurocrine BioSciences, Inc.15$351
ABBVIE INC.26$279
E.R. Squibb & Sons, L.L.C.12$239
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$228
Otsuka America Pharmaceutical, Inc.12$178
Collegium Pharmaceutical, Inc.15$166
Almatica Pharma LLC6$121
Janssen Pharmaceuticals, Inc4$120
Axsome Therapeutics, Inc.5$110

Products named: INGREZZA, VRAYLAR, FANAPT, COBENFY, CAPLYTA, Jornay PM, REXULTI, LOREEV XR.

Industry payments across VA — which companies pay providers there.